- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2095-0225
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Activation of phagocytosis by immune checkpoint blockade ; volume:12 ; number:4 ; day:30 ; month:7 ; year:2018 ; pages:473-480 ; date:8.2018
Frontiers of medicine ; 12, Heft 4 (30.7.2018), 473-480, 8.2018
- Urheber
-
Li, Chia-Wei
Lai, Yun-Ju
Hsu, Jennifer L.
Hung, Mien-Chie
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11684-018-0657-5
- URN
-
urn:nbn:de:101:1-2018122319290617921936
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek.
Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, Chia-Wei
- Lai, Yun-Ju
- Hsu, Jennifer L.
- Hung, Mien-Chie
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade
Tumor immunosurveiliance: Innate immune activation as a mechanistic prerequisite for efficient immune checkpoint blockade in cancer immunotherapy
Microbial biomarkers for immune checkpoint blockade therapy against cancer
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Regulatory T cells in immune checkpoint blockade antitumor therapy
Prospects for combining immune checkpoint blockade with PARP inhibition
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers
Correction to: Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade
Tumor immunosurveiliance: Innate immune activation as a mechanistic prerequisite for efficient immune checkpoint blockade in cancer immunotherapy
Microbial biomarkers for immune checkpoint blockade therapy against cancer
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Regulatory T cells in immune checkpoint blockade antitumor therapy
Prospects for combining immune checkpoint blockade with PARP inhibition
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers
Correction to: Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade
Tumor immunosurveiliance: Innate immune activation as a mechanistic prerequisite for efficient immune checkpoint blockade in cancer immunotherapy
Microbial biomarkers for immune checkpoint blockade therapy against cancer
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Regulatory T cells in immune checkpoint blockade antitumor therapy
Prospects for combining immune checkpoint blockade with PARP inhibition
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers